Biomimetic Technology to "Fool" Viruses
A "nanoviricide" is an agent designed by the Company to fool a virus into attaching to this antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface. Once attached, the flexible nanoviricide glob wraps around the virus and traps it. In the process, the virus also loses its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. A nanoviricide completes the task of dismantling the virus particle without immune system assistance. This is the putative or designed mechanism of action of a nanoviricide. Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines), which are currently well established antiviral strategies.
A nanoviricide is large enough for a virus particle to latch onto it. Yet small enough to circulate readily in the body. Rather than the virus particle entering into a nanoviricide, a nanoviricide wraps around the virus particle and encapsulates it, by using the virus particle's very same ability to enter a cell.
NanoViricides In the News
- 04-28-2015 NYSE Publishes Article on NanoViricides
- NanoViricides May Be on the Verge of a Whole New Era in Medicine
- 04-15-2014 NanoViricides won the IAIR AWARD
- 02-20-2014Dr. Anil R. Diwan Recognized as "Researcher of the year".
Latest Interviews & Presentations
Dr. Diwan invented novel polymeric micelle-based nanomedicine technologies
Anil R. DiwanChairman & President
Dr. Seymour became a consultant to the UN Global Program on AIDS
Eugene SeymourChief Executive Officer
Ms. Vyas was First Indian woman to be named CEO of a publicly listed US corporation
Meeta VyasChief Financial Officer
Dr. Barton has over 25 years experience in drug discovery and development
Randall BartonChief Scientific Officer
1 Controls Drive,
Shelton, CT 06484